Yibing Shan

Yibing Shan

Directeur Technique/Scientifique/R&D chez Bakx Therapeutics, Inc.

Consumer Services
Health Technology
Finance

Profil

Yibing Shan is currently the Director & Chief Computational Scientist at Bakx Therapeutics, Inc. He is also the Founding Managing Director at AB Magnitude Ventures Group, LLC and Antidote Health Foundation For Cure of Cancer.
Additionally, he works as a Technical Consultant at D.E.
Shaw Research LLC.
Previously, he served as a Member of the Board of Reviewing Editors at eLife Sciences Publications Ltd.
from 2015 to 2021.
Dr. Shan received his graduate and doctorate degrees from Drexel University in 2000 and his undergraduate degree from the University of Shanghai for Science & Technology.

Postes actifs de Yibing Shan

SociétésPosteDébut
Directeur Technique/Scientifique/R&D -
Private Equity Investor 01/04/2021
Consultant / Advisor 01/10/2020
Tous les postes actifs de Yibing Shan

Anciens postes connus de Yibing Shan

SociétésPosteFin
Directeur/Membre du Conseil 01/12/2021
Voir l'expérience en détail de Yibing Shan

Formation de Yibing Shan

Drexel University Doctorate Degree
University of Shanghai for Science & Technology Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Yibing Shan

Relations

76

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées4

Health Technology

Consumer Services

Finance

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Yibing Shan